CDKN2A and atherosclerosis: For example, whole-body deficiency of the other gene product of CDKN2A, i.e. p19ARF, aggravates atherosclerosis development in apoe−/− mice, although the exact mechanisms and cell types involved in vivo remained elusive [11].